• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核心脏病学中诊断和预后建模的生物统计学与经济学方法入门:第一部分。

A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I.

作者信息

Shaw L J, Hachamovitch R, Eisenstein E L, Kesler K L, Heller G V, Miller D D

机构信息

Outcomes Assessment Group, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

J Nucl Cardiol. 1996 Nov-Dec;3(6 Pt 1):538-45. doi: 10.1016/s1071-3581(96)90062-8.

DOI:10.1016/s1071-3581(96)90062-8
PMID:8989677
Abstract

This review presents a brief overview of existing diagnostic and prognostic methodologies to be used for the evaluation of patients undergoing noninvasive testing. In part I of this review, we will present methods for use of logistic and Cox regression analyses in determining the diagnostic and prognostic value of nuclear imaging techniques. In part II of this review, we will present an outline for the integration of economic evaluations into the clinical decision-making process. This review will document how cost estimates may be defined as well as the differing type of cost analyses (i.e., cost efficiency versus cost-effectiveness).

摘要

本综述简要概述了用于评估接受非侵入性检查患者的现有诊断和预后方法。在本综述的第一部分,我们将介绍在确定核成像技术的诊断和预后价值时使用逻辑回归和Cox回归分析的方法。在本综述的第二部分,我们将概述如何将经济评估纳入临床决策过程。本综述将记录成本估算如何定义以及不同类型的成本分析(即成本效率与成本效益)。

相似文献

1
A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part I.核心脏病学中诊断和预后建模的生物统计学与经济学方法入门:第一部分。
J Nucl Cardiol. 1996 Nov-Dec;3(6 Pt 1):538-45. doi: 10.1016/s1071-3581(96)90062-8.
2
A primer of biostatistic and economic methods for diagnostic and prognostic modeling in nuclear cardiology: Part II.
J Nucl Cardiol. 1997 Jan-Feb;4(1 Pt 1):52-60. doi: 10.1016/s1071-3581(97)90049-0.
3
Cost-effectiveness of nuclear cardiology.
J Nucl Cardiol. 1997 Mar-Apr;4(2 Pt 2):S139-40. doi: 10.1016/s1071-3581(97)90092-1.
4
[Role of noninvasive examinations in the management of ischemic heart disease.IV. Nuclear cardiology in chronic ischemic heart disease].[无创检查在缺血性心脏病管理中的作用。IV. 慢性缺血性心脏病中的核素心脏病学]
Rev Esp Cardiol. 1997 Feb;50(2):83-91. doi: 10.1016/s0300-8932(97)73184-1.
5
Evaluating the benefits of nuclear cardiology.
Q J Nucl Med. 1996 Mar;40(1):47-54.
6
[Diagnosis and prognosis of elderly patients with coronary artery disease: assessment with dipyridamole thallium imaging].[老年冠心病患者的诊断与预后:双嘧达莫铊显像评估]
J Cardiol. 1995 Oct;26(4):219-26.
7
Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data.运动铊-201单光子发射计算机断层扫描对主要缺血事件的长期预测。与临床、运动试验、心导管检查和放射性核素血管造影数据相比的增量预后价值。
J Am Coll Cardiol. 1995 Oct;26(4):879-86. doi: 10.1016/0735-1097(95)00243-9.
8
Survival analysis for cardiac risk stratification.用于心脏风险分层的生存分析。
J Gen Intern Med. 1999 Jul;14(7):451-3. doi: 10.1046/j.1525-1497.1999.03249.x.
9
Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data.连续放射性核素血管造影术在预测冠状动脉旁路移植术后心源性死亡中的应用及其与临床和心导管检查数据的比较。
Am J Cardiol. 1997 Apr 1;79(7):851-5. doi: 10.1016/s0002-9149(97)00002-7.
10
Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing.利用运动心肌灌注单光子发射计算机断层扫描对女性进行有效的风险分层:预后核素检查中的性别差异
J Am Coll Cardiol. 1996 Jul;28(1):34-44. doi: 10.1016/0735-1097(96)00095-2.

引用本文的文献

1
Cardiovascular risk assessment models: Have we found the perfect solution yet?心血管风险评估模型:我们找到完美的解决方案了吗?
J Nucl Cardiol. 2020 Dec;27(6):2375-2385. doi: 10.1007/s12350-019-01642-x. Epub 2019 Feb 21.
2
Statistical analysis of medical data. Part I: Univariable analysis.医学数据的统计分析。第一部分:单变量分析。
J Nucl Cardiol. 2000 Mar-Apr;7(2):146-52. doi: 10.1016/s1071-3581(00)90035-7.
3
Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group.

本文引用的文献

1
A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging.一项对急性心肌梗死后出院前风险分层的荟萃分析,采用了运动心电图、心肌灌注和心室功能成像技术。
Am J Cardiol. 1996 Dec 15;78(12):1327-37. doi: 10.1016/s0002-9149(96)00653-4.
2
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.多变量预后模型:模型开发、评估假设与充分性以及测量和减少误差方面的问题。
Stat Med. 1996 Feb 28;15(4):361-87. doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.
3
J Nucl Cardiol. 1999 Nov-Dec;6(6):559-69. doi: 10.1016/s1071-3581(99)90091-0.
4
Prognostic characterization of patients with mild coronary artery disease with myocardial perfusion single photon emission computed tomography: validation of an outcomes-based strategy.
J Nucl Cardiol. 1998 Jan-Feb;5(1):90-5. doi: 10.1016/s1071-3581(98)80016-0.
Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification.
无已知冠状动脉疾病患者的运动心肌灌注单光子发射计算机断层扫描:增量预后价值及在风险分层中的应用
Circulation. 1996 Mar 1;93(5):905-14. doi: 10.1161/01.cir.93.5.905.
4
Value of the history and physical in identifying patients at increased risk for coronary artery disease.病史和体格检查在识别冠心病高危患者中的价值。
Ann Intern Med. 1993 Jan 15;118(2):81-90. doi: 10.7326/0003-4819-118-2-199301150-00001.
5
Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group.医学文献用户指南。III. 如何使用一篇关于诊断试验的文章。B. 结果是什么,它们对我照顾患者有帮助吗?循证医学工作组。
JAMA. 1994 Mar 2;271(9):703-7. doi: 10.1001/jama.271.9.703.
6
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.冠状动脉疾病治疗方法的持续演变。冠状动脉成形术时代的初步结果。
Circulation. 1994 May;89(5):2015-25. doi: 10.1161/01.cir.89.5.2015.
7
Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease.疑似冠心病患者无创评估与管理中的性别差异。
Ann Intern Med. 1994 Apr 1;120(7):559-66. doi: 10.7326/0003-4819-120-7-199404010-00005.
8
A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST).一项比较冠状动脉血管成形术与冠状动脉搭桥手术的随机试验。埃默里血管成形术与手术试验(EAST)。
N Engl J Med. 1994 Oct 20;331(16):1044-50. doi: 10.1056/NEJM199410203311602.
9
A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarction.一项预测心肌梗死后患者左心室射血分数保留情况的临床规则。
Ann Intern Med. 1994 Nov 15;121(10):750-6. doi: 10.7326/0003-4819-121-10-199411150-00004.
10
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.冠状动脉搭桥手术对生存率的影响:冠状动脉搭桥手术试验协作组随机试验10年结果概述
Lancet. 1994 Aug 27;344(8922):563-70. doi: 10.1016/s0140-6736(94)91963-1.